Hepatitis C drug stocks back in play By: MarketWatch April 19, 2012 at 13:14 PM EDT Hepatitis C specialists Gilead, Idenix and Achillion were back in play Thursday, as investors reacted to positive data on Gilead’s experimental drug GS-7977. Read More >> Related Stocks: Achison Inc Bristol-Myers Squibb Gilead Sciences